Avance Clinical is a full-service contract research organisation (CRO) that provides clinical research capabilities for biotech companies worldwide. The company specialises in offering high-touch clinical trial solutions tailored to clients’ individual needs.

In this interview with Pharmaceutical Technology, Avance CEO Yvonne Lungershausen outlines the company’s services and what sets it apart from other CROs in the biotech sector, as well as its expansion plans for the near future.